European Journal of Immunology

Papers
(The TQCC of European Journal of Immunology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)252
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset180
Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients108
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action98
Human NK cells, their receptors and function96
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno‐oncology treatments94
Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy82
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans67
Highly multiplexed tissue imaging using repeated oligonucleotide exchange reaction66
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR1564
Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway62
The expanding world of tissue‐resident macrophages60
JAK inhibitors: Ten years after58
Treg cell therapy: How cell heterogeneity can make the difference58
Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease57
CD8+ Tregs revisited: A heterogeneous population with different phenotypes and properties53
Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients51
High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris50
Complement cascade in severe forms of COVID‐19: Recent advances in therapy47
Helios is a marker, not a driver, of human Treg stability46
CAR T cells: Building on the CD19 paradigm45
Peptide microarray‐based analysis of antibody responses to SARS‐CoV‐2 identifies unique epitopes with potential for diagnostic test development44
Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients43
Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis41
Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritis40
Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy40
Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease40
Differential Interleukin‐8 thresholds for chemotaxis and netosis in human neutrophils39
Altered increase in STAT1 expression and phosphorylation in severe COVID‐1939
Metabolic reprograming shapes neutrophil functions in severe COVID‐1939
Regulatory T‐cell development in the tumor microenvironment37
Icaritin inhibits PD‐L1 expression by Targeting Protein IκB Kinase α36
The role of the gut microbiota and microbial metabolites in neuroinflammation36
Anti‐heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID‐1936
IL‐17A expressed on neutrophil extracellular traps promotes mesenchymal stem cell differentiation toward bone‐forming cells in ankylosing spondylitis35
A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice34
Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver33
Differential sensitivity of inflammatory macrophages and alternatively activated macrophages to ferroptosis32
Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity32
Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination32
Molecular mechanisms of nonself nucleic acid recognition by the innate immune system31
Altered IgG glycosylation at COVID‐19 diagnosis predicts disease severity30
Tumor‐associated human dendritic cell subsets: Phenotype, functional orientation, and clinical relevance30
CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver30
An integrative genomics approach identifies KDM4 as a modulator of trained immunity29
The role of cGAS/STING in intestinal immunity29
IL‐33/ST2 as a potential target for tumor immunotherapy28
Protection against allergies: Microbes, immunity, and the farming effect28
Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection28
Antigen‐driven PD‐1+TOX+BHLHE40+ and PD‐1+TOX+EOMES+ T lymphocytes regulate juvenile idiopathic arthritis 27
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS‐CoV‐2 infection27
Collagen type VI is the antigen recognized by the ER‐TR7 antibody27
Neuroimmune interactions in peripheral tissues26
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects26
Systematic analysis of CD39, CD103, CD137, and PD‐1 as biomarkers for naturally occurring tumor antigen‐specific TILs26
Mechanisms of exTreg induction26
Human dendritic cell subsets: An updated view of their ontogeny and functional specialization26
RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches25
Enrichment of CCR6+CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID‐1925
Identification of human cytotoxic ILC3s25
Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches25
T cells at work: How post‐transcriptional mechanisms control T cell homeostasis and activation24
The association of Epstein‐Barr virus infection with CXCR3+ B‐cell development in multiple sclerosis: impact of immunotherapies24
Regulation of the humoral type 2 immune response against allergens and helminths24
Measuring single‐cell protein secretion in immunology: Technologies, advances, and applications24
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients23
Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects23
Tryptophan and the innate intestinal immunity: Crosstalk between metabolites, host innate immune cells, and microbiota23
Maintenance of quiescent immune memory in the bone marrow23
CD5 levels define functionally heterogeneous populations of naïve human CD4+ T cells22
Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapy22
TLR7 endogenous ligands remodel glycolytic macrophages and trigger skin‐to‐joint crosstalk in psoriatic arthritis22
Deep phenotypical characterization of human CD3+CD56+ T cells by mass cytometry22
Autophagy regulates long‐term cross‐presentation by murine dendritic cells22
CTRP4 acts as an anti‐inflammatory factor in macrophages and protects against endotoxic shock22
Mesenchymal stromal cells‐derived small extracellular vesicles modulate DC function to suppress Th2 responses via IL‐10 in patients with allergic rhinitis21
Innate lymphoid cells and cancer: Role in tumor progression and inhibition21
HLA‐DRB1*15:01 is a co‐receptor for Epstein–Barr virus, linking genetic and environmental risk factors for multiple sclerosis21
Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive21
Towards gene therapy for IPEX syndrome20
Metabolic dynamics instruct CD8+ T‐cell differentiation and functions20
T‐cell memory in tissues20
High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐220
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing20
PD‐1‐specific “Blocking” antibodies that deplete PD‐1+ T cells present an inconvenient variable in preclinical immunotherapy experiments19
ACKR1 favors transcellular over paracellular T‐cell diapedesis across the blood‐brain barrier in neuroinflammation in vitro19
Cross talk between human regulatory T cells and antigen‐presenting cells: Lessons for clinical applications19
Mutant B2M‐HLA‐E and B2M‐HLA‐G fusion proteins protects universal chimeric antigen receptor‐modified T cells from allogeneic NK cell‐mediated lysis19
ChAdOx1‐S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination19
GSDMD‐mediated NETosis promotes the development of acute respiratory distress syndrome18
Evolved to protect, designed to destroy: IL‐17‐producing γδ T cells in infection, inflammation, and cancer18
The thioredoxin system: Balancing redox responses in immune cells and tumors18
Human liver‐derived MAIT cells differ from blood MAIT cells in their metabolism and response to TCR‐independent activation18
SARS‐CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR1018
Sex differences regulate immune responses in experimental autoimmune encephalomyelitis and multiple sclerosis18
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model18
Specificity of mouse and human Fcgamma receptors and their polymorphic variants for IgG subclasses of different species18
Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions18
Heterogeneity of germinal center B cells: New insights from single‐cell studies18
The presence of serum anti‐SARS‐CoV‐2 IgA appears to protect primary health care workers from COVID‐1917
De novo polyamine synthesis supports metabolic and functional responses in activated murine NK cells17
Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas–intestinal barrier axis17
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3‐dioxygenase 1 with functional effects on T cell priming17
Emerging imaging and liquid biomarkers in multiple sclerosis17
Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS‐CoV‐2 Spike protein16
Recognition of S100 proteins by Signal Inhibitory Receptor on Leukocytes‐1 negatively regulates human neutrophils16
Insights into coronavirus immunity taught by the murine coronavirus16
Towards prevention of autoimmune diseases: The example of rheumatoid arthritis16
Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities16
Interleukin‐21 in autoimmune and inflammatory skin diseases16
IgE in the pathophysiology and therapy of food allergy16
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods16
Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL‐2 expression to ameliorate DSS‐induced colitis16
Withdrawn16
4‐1BB costimulation promotes bystander activation of human CD8 T cells16
Driving T cells to human atherosclerotic plaques: CCL3/CCR5 and CX3CL1/CX3CR1 migration axes16
CCL25 and CCR9 is a unique pathway that potentiates pannus formation by remodeling RA macrophages into mature osteoclasts15
Regulatory T cells as a therapeutic approach for inflammatory bowel disease15
miR‐148a controls metabolic programming and survival of mature CD19‐negative plasma cells in mice15
AIDS patient with severe T cell depletion achieved control but not clearance of SARS‐CoV‐2 infection15
Characterization of SARS‐CoV‐2 and common cold coronavirus‐specific T‐cell responses in MIS‐C and Kawasaki disease children15
Four challenges to CAR T cells breaking the glass ceiling15
Differential effects of estradiol and progesterone on human T cell activation in vitro14
Immunological analysis of the murine anti‐CD3‐induced cytokine release syndrome model and therapeutic efficacy of anti‐cytokine antibodies14
Ursodeoxycholic acid impairs liver‐infiltrating T‐cell chemotaxis through IFN‐γ and CX3CL1 production in primary biliary cholangitis14
Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders14
Human NK cells responses are enhanced by CD56 engagement14
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection14
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer14
Autoantibodies targeting type I interferons: Prevalence, mechanisms of induction, and association with viral disease susceptibility14
T helper cell subsets: diversification of the field14
Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice13
Abortive HIV‐1 RNA induces pro‐IL‐1β maturation via protein kinase PKR and inflammasome activation in humans13
cGAS‐STING signaling in cell death: Mechanisms of action and implications in pathologies13
Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity13
TFF3 mediates the NF‐κB/COX2 pathway to regulate PMN‐MDSCs activation and protect against necrotizing enterocolitis13
Broadly reactive human CD4+ T cells against Enterobacteriaceae are found in the naïve repertoire and are clonally expanded in the memory repertoire13
Hobit and Blimp‐1 regulate TRM abundance after LCMV infection by suppressing tissue exit pathways of TRMprecursors13
Langerhans cells in the skin and oral mucosa: Brothers in arms?12
Classical DC2 subsets and monocyte‐derived DC: Delineating the developmental and functional relationship12
Splenic erythroid progenitors decrease TNF‐α production by macrophages and reduce systemic inflammation in a mouse model of T cell‐induced colitis12
Guidelines for mouse and human DC generation12
Human myeloid‐derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data12
Loss of microRNA‐147 function alleviates synovial inflammation through ZNF148 in rheumatoid and experimental arthritis12
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR‐engineered T cells12
Epigenetic regulation in antiviral innate immunity12
Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells12
EGFR ligands synergistically increase IL‐17A‐induced expression of psoriasis signature genes in human keratinocytes via IκBζ and Bcl312
Guidelines for standardizing T‐cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes12
Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients12
Macrophage plasticity as a therapeutic target in tuberculosis12
Human CXCR5+PD‐1+ CD8 T cells in healthy individuals and patients with hematologic malignancies12
mTOR‐dependent immunometabolism as Achilles' heel of anticancer therapy11
Altered follicular regulatory T (Tfr)‐ and helper T (Tfh)‐cell subsets are associated with autoantibody levels in microscopic polyangiitis patients11
Macrophage and monocyte subsets in response to ischemic stroke11
Mast cells in type 2 skin inflammation: Maintenance and function11
Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice11
Eomesodermin‐expressing type 1 regulatory (EOMES+Tr1)‐like T cells: Basic biology and role in immune‐mediated diseases11
One year of Young EFIS: achievements and future directions11
UNC93B1 curbs cytosolic DNA signaling by promoting STING degradation11
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies11
TRIM10 binds to IFN‐α/β receptor 1 to negatively regulate type I IFN signal transduction11
Interleukin‐34 accelerates intrauterine adhesions progress related to CX3CR1+ monocytes/macrophages11
Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity11
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity11
Dendritic cells Trigger IFN‐γ secretion by NK cells independent of IL‐12 and IL‐1810
Structure‐guided stabilization of pathogen‐derived peptide‐HLA‐E complexes using non‐natural amino acids conserves native TCR recognition10
Bystander activation of Bordetella pertussis‐induced nasal tissue‐resident memory CD4 T cells confers heterologous immunity to Klebsiella pneumoniae10
Stereotyped B‐cell responses are linked to IgG constant region polymorphisms in multiple sclerosis10
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency10
Commensal fungi and their cell‐wall β‐glucans direct differential responses in human intestinal epithelial cells10
Mass cytometry analysis of blood immune cells from psoriasis patients on biological therapy10
Monocytes mediate Salmonella Typhimurium‐induced tumor growth inhibition in a mouse melanoma model10
Epstein Barr virus infection and immune defense related to HLA‐DR15: consequences for multiple sclerosis10
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation10
Resolving trained immunity with systems biology10
TNFR2 expression is a hallmark of human memory B cells with suppressive function10
Effect of everolimus‐based drug regimens on CMV‐specific T‐cell functionality after renal transplantation: 12‐month ATHENA subcohort‐study results10
Profiling the specificity of clonally expanded plasma cells during chronic viral infection by single‐cell analysis10
Single‐cell resolution of plasma cell fate programming in health and disease10
Plasmacytoid dendritic cells regulate host immune response to Citrobacter rodentium induced colitis in colon‐draining lymph nodes10
Phospholipase activity of acyloxyacyl hydrolase induces IL‐22‐producing CD1a‐autoreactive T cells in individuals with psoriasis10
COVID‐19 rapidly increases MDSCs and prolongs innate immune dysfunctions10
Single‐reaction multi‐antigen serological test for comprehensive evaluation of SARS‐CoV‐2 patients by flow cytometry10
GFI1/HDAC1‐axis differentially regulates immunosuppressive CD73 in human tumor‐associated FOXP3+Th17 and inflammation‐linked Th17 cells10
P2X7 is expressed on human innate‐like T lymphocytes and mediates susceptibility to ATP‐induced cell death10
SARS‐CoV‐2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs10
A conserved pathway of transdifferentiation in murine Kupffer cells10
GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity10
IL‐3 regulates the differentiation of pathogenic Th17 cells9
Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells9
Antigen targeting to dendritic cells: Still a place in future immunotherapy?9
Metabolic and inflammatory reprogramming of macrophages by ONC201 translates in a pro‐inflammatory environment even in presence of glioblastoma cells9
Specific detection of memory T‐cells in COVID‐19 patients using standardized whole‐blood Interferon gammarelease assay9
Genetic dissection of a major haplotype associated with arthritis reveal FcγR2b and FcγR3 to act additively9
ILC1: Development, maturation, and transcriptional regulation9
Peptidylprolyl isomerase C (Ppic) regulates invariant Natural Killer T cell (iNKT) differentiation in mice9
Dendritic cell functions in vivo: A user's guide to current and next‐ generation mutant mouse models9
Fibroblastic reticular cells provide a supportive niche for lymph node–resident macrophages9
Zbtb10 transcription factor is crucial for murine cDC1 activation and cytokine secretion9
Multiomics uncovers developing immunological lineages in human9
Endoplasmic reticulum stress and the inflammatory response in allergic contact dermatitis9
Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8+ T cells and limit CD4+ T‐cell loss in BLT mice9
CRISPR/Cas9 editing in conditionally immortalized HoxB8 cells for studying gene regulation in mouse dendritic cells9
Identification of the Fc‐alpha/mu receptor in Xenopus provides insight into the emergence of the poly‐Ig receptor (pIgR) and mucosal Ig transport9
Circulating ILC precursors expressing CD62L exhibit a type 2 signature distinctly decreased in psoriatic patients9
Regulatory T cells and transplantation tolerance: Emerging from the darkness?9
Acquisition of human plasminogen facilitates complement evasion by the malaria parasite Plasmodium falciparum9
T‐cell subsets in allergy and tolerance induction9
9‐cis Retinoic acid and 1.25‐dihydroxyvitamin D3 drive differentiation into IgA+ secreting plasmablasts in human naïve B cells9
CD11c identifies microbiota and EGR2‐dependent MHCII+ serous cavity macrophages with sexually dimorphic fate in mice9
SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination9
Discriminating promiscuous from target‐specific autoantibodies in COVID‐199
Nitrosonisoldipine is a selective inhibitor of inflammatory caspases and protects against pyroptosis and related septic shock9
Identification of the predominant human NK cell effector subset mediating ADCC against HIV‐infected targets coated with BNAbs or plasma from PLWH9
Systemic lupus erythematosus patients contain B‐cell receptor repertoires sensitive to immunosuppressive drugs9
Checkpoints controlling the induction of B cell mediated autoimmunity in human autoimmune diseases9
Drosophila Relish‐mediated miR‐317 expression facilitates immune homeostasis restoration via inhibiting PGRP‐LC9
Musculin is highly enriched in Th17 and IL‐22‐producing ILC3s and restrains pro‐inflammatory cytokines in murine colitis9
Complement, complosome, and complotype: A perspective8
Differentiation and activation of human CD4 T cells is associated with a gradual loss of myelin and lymphocyte protein8
Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination8
A few good reasons to use nanobodies for cancer treatment8
Intestinal CD8+ tissue‐resident memory T cells: From generation to function8
SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function8
Guidelines for DC preparation and flow cytometry analysis of mouse nonlymphoid tissues8
Cytosolic d‐type CpG‐oligonucleotides induce a type I interferon response by activating the cGAS‐STING signaling pathway8
CD28 is expressed by macrophages with anti‐inflammatory potential and limits their T‐cell activating capacity8
IL‐13 determines specific IgE responses and SARS‐CoV‐2 immunity after mild COVID‐19 and novel mRNA vaccination8
Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy8
Termination of CD40L co‐stimulation promotes human B cell differentiation into antibody‐secreting cells8
Imprint of unconventional T‐cell response in acute hepatitis C persists despite successful early antiviral treatment8
Tumor cell‐intrinsic RIG‐I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice8
Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants‐enriched diffuse large B‐cell lymphomas8
c‐Rel employs multiple mechanisms to promote the thymic development and peripheral function of regulatory T cells in mice8
Advances in experimental models of rheumatoid arthritis8
Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity8
Eosinophils interact with thymocytes and proliferate in the human thymus7
Flow cytometry‐based high‐throughput RNAi screening for miRNAs regulating MHC class II HLA‐DR surface expression7
Advances in Liver Transplantation: where are we in the pursuit of transplantation tolerance?7
Isolation and expansion of thymus‐derived regulatory T cells for use in pediatric heart transplant patients7
Assessing anti‐SARS‐CoV‐2 cellular immunity in 571 vaccines by using an IFN‐γ release assay7
Ubiquitination network in the type I IFN‐induced antiviral signaling pathway7
Cryptococcus gattii evades CD11b‐mediated fungal recognition by coating itself with capsular polysaccharides7
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome7
Homologous and heterologous serological response to the N‐terminal domain of SARS‐CoV‐2 in humans and mice7
Diet, commensal microbiota‐derived extracellular vesicles, and host immunity7
SLAMF7 selectively favors degranulation to promote cytotoxicity in human NK cells7
Myeloid‐derived suppressor cells in the therapy of autoimmune diseases7
Z‐nucleic acids: Uncovering the functions from past to present7
0.052027940750122